Phreesia (NYSE:PHR) Stock Price Down 6.7% – What’s Next?

Posted by Brenda Bartman on Aug 17th, 2026

Phreesia, Inc. (NYSE:PHR – Get Free Report) fell 6.7% during mid-day trading on Monday . The stock traded as low as $11.45 and last traded at $11.46. Approximately 388,277 shares changed hands during trading, a decline of 75% from the average session volume of 1,548,201 shares. The stock had previously closed at $12.28.

Wall Street Analyst Weigh In

PHR has been the subject of a number of recent research reports. Wall Street Zen upgraded Phreesia from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Citigroup restated a “market perform” rating on shares of Phreesia in a research report on Friday, May 29th. Canaccord Genuity Group dropped their price objective on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, May 28th. Wells Fargo & Company reiterated an “equal weight” rating and set a $9.00 price objective (down from $15.00) on shares of Phreesia in a research report on Wednesday, May 20th. Finally, Barclays reissued an “equal weight” rating and issued a $10.00 target price (down from $24.00) on shares of Phreesia in a research note on Thursday, May 14th. Nine equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Phreesia has an average rating of “Hold” and an average price target of $16.65.

Read Our Latest Report on PHR

Phreesia Stock Performance

The firm has a 50-day moving average price of $10.52 and a two-hundred day moving average price of $10.59. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market capitalization of $709.58 million, a P/E ratio of 76.53 and a beta of 0.85.

Phreesia (NYSE:PHR – Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The company had revenue of $130.94 million during the quarter, compared to analysts’ expectations of $130.08 million. During the same period in the previous year, the company earned ($0.07) EPS. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. On average, analysts forecast that Phreesia, Inc. will post 0.39 EPS for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Institutional investors and hedge funds have recently bought and sold shares of the company. Van ECK Associates Corp grew its position in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after buying an additional 1,102 shares in the last quarter. Rockefeller Capital Management L.P. raised its holdings in shares of Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Phreesia by 1,119.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares during the period. KBC Group NV grew its holdings in Phreesia by 83.4% during the 4th quarter. KBC Group NV now owns 3,449 shares of the company’s stock worth $58,000 after acquiring an additional 1,568 shares in the last quarter. Finally, Garner Asset Management Corp purchased a new position in Phreesia during the 4th quarter valued at about $81,000. 92.10% of the stock is owned by institutional investors.

About Phreesia

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.